Class information for:
Level 1: ANTIDIABETIC PHARMACOTHERAPY//A HEFT//ACORN CSD

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
25009 294 38.1 85%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
8 4 CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL 1276458
62 3       CARDIAC & CARDIOVASCULAR SYSTEM//HEART FAILURE//PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY 86105
942 2             HEART FAILURE//ACUTE HEART FAILURE//EUROPEAN JOURNAL OF HEART FAILURE 10944
25009 1                   ANTIDIABETIC PHARMACOTHERAPY//A HEFT//ACORN CSD 294

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 ANTIDIABETIC PHARMACOTHERAPY authKW 207723 1% 100% 2
2 A HEFT authKW 103861 0% 100% 1
3 ACORN CSD authKW 103861 0% 100% 1
4 AHMANSAN UCLA CARDIOMYOPATHY address 103861 0% 100% 1
5 ALCOHOLIC MYOCARDIOPATHY authKW 103861 0% 100% 1
6 ANTIHYPERGLYCEMIC TREATMENT authKW 103861 0% 100% 1
7 CARDIAC ARRHYTHMIA UNIT MED address 103861 0% 100% 1
8 CARDIO METAB NUTR ICAN address 103861 0% 100% 1
9 CARDIOGERIAT address 103861 0% 100% 1
10 CARDIOLW CAMPUS NONINVAS CARDIOL address 103861 0% 100% 1

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Cardiac & Cardiovascular System 8573 66% 0% 195
2 Endocrinology & Metabolism 516 17% 0% 50
3 Peripheral Vascular Diseases 100 6% 0% 18
4 Medicine, General & Internal 73 9% 0% 26
5 Nursing 10 1% 0% 4
6 Engineering, Biomedical 3 1% 0% 4
7 Medicine, Research & Experimental 3 2% 0% 7
8 Medical Informatics 1 0% 0% 1
9 Respiratory System 1 1% 0% 3
10 Transplantation 0 1% 0% 2

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 AHMANSAN UCLA CARDIOMYOPATHY 103861 0% 100% 1
2 CARDIAC ARRHYTHMIA UNIT MED 103861 0% 100% 1
3 CARDIO METAB NUTR ICAN 103861 0% 100% 1
4 CARDIOGERIAT 103861 0% 100% 1
5 CARDIOLW CAMPUS NONINVAS CARDIOL 103861 0% 100% 1
6 CARDIOPULM MANAGEMENT PROGRAM 103861 0% 100% 1
7 DIAGNOST SUPPORT PRIMARY 103861 0% 100% 1
8 DIAGNOST SUPPORT PRIMARY CARE SHL 103861 0% 100% 1
9 DW REYNOLDS CARDIOVASC 103861 0% 100% 1
10 EPIDEMIOL MODELING UNIT 103861 0% 100% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 EUROPEAN JOURNAL OF HEART FAILURE 42357 11% 1% 31
2 JOURNAL OF CARDIAC FAILURE 15535 5% 1% 16
3 CIRCULATION-HEART FAILURE 9742 3% 1% 9
4 DIABETES STOFFWECHSEL UND HERZ 3703 1% 1% 3
5 DIABETES & VASCULAR DISEASE RESEARCH 2314 1% 1% 3
6 DIABETOLOGE 2138 1% 1% 3
7 INTERNATIONAL JOURNAL OF CARDIOLOGY 1962 5% 0% 15
8 HEART 1907 3% 0% 10
9 DIABETES CARE 1525 4% 0% 13
10 JACC-HEART FAILURE 1395 1% 1% 2

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 ANTIDIABETIC PHARMACOTHERAPY 207723 1% 100% 2 Search ANTIDIABETIC+PHARMACOTHERAPY Search ANTIDIABETIC+PHARMACOTHERAPY
2 A HEFT 103861 0% 100% 1 Search A+HEFT Search A+HEFT
3 ACORN CSD 103861 0% 100% 1 Search ACORN+CSD Search ACORN+CSD
4 ALCOHOLIC MYOCARDIOPATHY 103861 0% 100% 1 Search ALCOHOLIC+MYOCARDIOPATHY Search ALCOHOLIC+MYOCARDIOPATHY
5 ANTIHYPERGLYCEMIC TREATMENT 103861 0% 100% 1 Search ANTIHYPERGLYCEMIC+TREATMENT Search ANTIHYPERGLYCEMIC+TREATMENT
6 CEREBRAL NATRIURETIC PEPTIDE 103861 0% 100% 1 Search CEREBRAL+NATRIURETIC+PEPTIDE Search CEREBRAL+NATRIURETIC+PEPTIDE
7 CONCOMITANT DIABETES 103861 0% 100% 1 Search CONCOMITANT+DIABETES Search CONCOMITANT+DIABETES
8 DIABETES MELLITUS TYPE 2 COMPLICATIONS DRUG THERAPY MORTALITY 103861 0% 100% 1 Search DIABETES+MELLITUS+TYPE+2+COMPLICATIONS+DRUG+THERAPY+MORTALITY Search DIABETES+MELLITUS+TYPE+2+COMPLICATIONS+DRUG+THERAPY+MORTALITY
9 GLYCEMIC IMPROVEMENT 103861 0% 100% 1 Search GLYCEMIC+IMPROVEMENT Search GLYCEMIC+IMPROVEMENT
10 HEART FAILURE INCIDENCE 103861 0% 100% 1 Search HEART+FAILURE+INCIDENCE Search HEART+FAILURE+INCIDENCE

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 GUGLIN, M , VILLAFRANCA, A , MORRISON, A , (2014) CARDIOGENIC DIABETES.HEART FAILURE REVIEWS. VOL. 19. ISSUE 5. P. 595 -602 25 66% 1
2 GOTSMAN, I , SHAUER, A , LOTAN, C , KEREN, A , (2014) IMPAIRED FASTING GLUCOSE: A PREDICTOR OF REDUCED SURVIVAL IN PATIENTS WITH HEART FAILURE.EUROPEAN JOURNAL OF HEART FAILURE. VOL. 16. ISSUE 11. P. 1190 -1198 22 65% 3
3 TARGHER, G , DAURIZ, M , LAROCHE, C , TEMPORELLI, PL , HASSANEIN, M , SEFEROVIC, PM , DROZDZ, J , FERRARI, R , ANKER, S , COATS, A , ET AL (2017) IN-HOSPITAL AND 1-YEAR MORTALITY ASSOCIATED WITH DIABETES IN PATIENTS WITH ACUTE HEART FAILURE: RESULTS FROM THE ESC-HFA HEART FAILURE LONG-TERM REGISTRY.EUROPEAN JOURNAL OF HEART FAILURE. VOL. 19. ISSUE 1. P. 54 -65 10 48% 2
4 DEATON, C , MAMAS, MA , RUTTER, MK , GIBSON, M , BOWELL, S , BYRNE, R , COEZY, K , GOW, J , WILLIAMS, S , (2011) GLUCOSE AND INSULIN ABNORMALITIES IN PATIENTS WITH HEART FAILURE.EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING. VOL. 10. ISSUE 2. P. 75-87 26 40% 7
5 SCHNEIDER, CA , PFISTER, R , ERDMANN, E , (2010) DIABETES AND HEART FAILURE.HERZ. VOL. 35. ISSUE 3. P. 140-146 22 48% 3
6 PFISTER, R , ERDMANN, E , (2008) DIABETES MELLITUS AND HEART FAILURE: EPIDEMIOLOGY AND THERAPY.HERZ. VOL. 33. ISSUE 3. P. 178-183 23 48% 4
7 MACDONALD, MR , PETRIE, MC , HAWKINS, NM , PETRIE, JR , FISHER, M , MCKELVIE, R , AGUILAR, D , KRUM, H , MCMURRAY, JJV , (2008) DIABETES, LEFT VENTRICULAR SYSTOLIC DYSFUNCTION, AND CHRONIC HEART FAILURE.EUROPEAN HEART JOURNAL. VOL. 29. ISSUE 10. P. 1224-1240 33 28% 67
8 KAMALESH, M , CLEOPHAS, TJ , (2009) HEART FAILURE DUE TO SYSTOLIC DYSFUNCTION AND MORTALITY IN DIABETES: POOLED ANALYSIS OF 39,505 SUBJECTS.JOURNAL OF CARDIAC FAILURE. VOL. 15. ISSUE 4. P. 305-309 16 57% 17
9 DE BOER, RA , DOEHNER, W , VAN DER HORST, ICC , ANKER, SD , BABALIS, D , ROUGHTON, M , COATS, AJ , FLATHER, MD , VAN VELDHUISEN, DJ , (2010) INFLUENCE OF DIABETES MELLITUS AND HYPERGLYCEMIA ON PROGNOSIS IN PATIENTS >= 70 YEARS OLD WITH HEART FAILURE AND EFFECTS OF NEBIVOLOL (DATA FROM THE STUDY OF EFFECTS OF NEBIVOLOL INTERVENTION ON OUTCOMES AND REHOSPITALIZATION IN SENIORS WITH HEART FAILURE [SENIORS]).AMERICAN JOURNAL OF CARDIOLOGY. VOL. 106. ISSUE 1. P. 78-86 16 55% 11
10 ROMERO, SP , GARCIA-EGIDO, A , ESCOBAR, MA , ANDREY, JL , CORZO, R , PEREZ, V , GARCIA-DOMIGUEZ, GJ , GOMEZ, F , (2013) IMPACT OF NEW-ONSET DIABETES MELLITUS AND GLYCEMIC CONTROL ON THE PROGNOSIS OF HEART FAILURE PATIENTS: A PROPENSITY-MATCHED STUDY IN THE COMMUNITY.INTERNATIONAL JOURNAL OF CARDIOLOGY. VOL. 167. ISSUE 4. P. 1206-1216 16 50% 7

Classes with closest relation at Level 1



Rank Class id link
1 3529 DIABETIC CARDIOMYOPATHY//DIABETIC HEART//ENVIRONM OCCUPAT AGR HLTH
2 10600 INTENS CARDIAC CORONARY UNIT//ADMISSION GLUCOSE//ADMISSION GLYCEMIA
3 17972 OBESITY CARDIOMYOPATHY//BARIATR SURG ANESTHESIA//CARDIAC REMODELING AND FUNCTION
4 1716 ACUTE HEART FAILURE//CARDIORENAL SYNDROME//NESIRITIDE
5 5486 CARDIAC METABOLISM//PROGRAM INTEGRAT CARDIAC METAB//HERITAGE MED 423
6 7532 HEART FAILURE WITH PRESERVED EJECTION FRACTION//PRESERVED EJECTION FRACTION//DIASTOLIC HEART FAILURE
7 3093 PIOGLITAZONE//THIAZOLIDINEDIONES//ROSIGLITAZONE
8 2021 BETA BLOCKERS//HEART FAILURE//CARVEDILOL
9 1188 HEART FAILURE//JOURNAL OF CARDIOVASCULAR NURSING//EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING
10 22786 GLICLAZIDE//ARTIFICIAL CELL MICROENCAPSULATION//BIOTECHNOL DRUG DEV

Go to start page